Hashad Yehia has filed 16 insider transactions across 2 companies since February 2024.
Most recent transaction: a tax payment of 11621 shares of Bausch & Lomb Corp ($BLCO) on February 27, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 27, 2026 | Bausch & Lomb Corp | $BLCO | Hashad Yehia | EVP of R&D and CMO | F | Common Shares, No Par Value | 11621 | $18.30 | 180,041.0000 | 354,318,198 | 6.06% | 0.00% |
| Feb. 27, 2026 | Bausch & Lomb Corp | $BLCO | Hashad Yehia | EVP of R&D and CMO | F | Common Shares, No Par Value | 5075 | $18.30 | 191,662.0000 | 354,318,198 | 2.58% | 0.00% |
| Feb. 26, 2026 | Bausch & Lomb Corp | $BLCO | Hashad Yehia | EVP of R&D and CMO | F | Common Shares, No Par Value | 2169 | $18.49 | 196,737.0000 | 354,318,198 | 1.09% | 0.00% |
| Feb. 25, 2026 | Bausch & Lomb Corp | $BLCO | Hashad Yehia | EVP of R&D and CMO | A | Common Shares, No Par Value | 35046 | $0.00 | 198,906.0000 | 354,318,198 | 21.39% | 0.01% |
| Feb. 18, 2026 | Bausch & Lomb Corp | $BLCO | Hashad Yehia | EVP of R&D and CMO | A | Common Shares, No Par Value | 29406 | $0.00 | 163,860.0000 | 354,318,198 | 21.87% | 0.01% |
| Aug. 5, 2025 | Bausch & Lomb Corp | $BLCO | Hashad Yehia | EVP of R&D and CMO | A | Common Shares, No Par Value | 17715 | $0.00 | 134,454.0000 | 352,470,796 | 15.17% | 0.01% |
| July 25, 2025 | Bausch & Lomb Corp | $BLCO | Hashad Yehia | EVP of R&D and CMO | F | Common Shares, No Par Value | 2841 | $14.32 | 116,739.0000 | 352,470,796 | 2.38% | 0.00% |
| March 8, 2025 | Unity Biotechnology, Inc. | $UNBX | Hashad Yehia | Not found | A | Stock Option (Right to Buy) | 20000 | $0.00 | 20,000.0000 | 16,867,647 | 9999.99% | 0.12% |
| Feb. 26, 2025 | Bausch & Lomb Corp | $BLCO | Hashad Yehia | EVP of R&D and CMO | A | Non-Qualified Stock Options (right to purchase) | 60085 | $0.00 | 60,085.0000 | 352,470,796 | 9999.99% | 0.02% |
| Feb. 26, 2025 | Bausch & Lomb Corp | $BLCO | Hashad Yehia | EVP of R&D and CMO | A | Common Shares, No Par Value | 25225 | $0.00 | 119,580.0000 | 352,470,796 | 26.73% | 0.01% |
| Dec. 23, 2024 | Bausch & Lomb Corp | $BLCO | Hashad Yehia | EVP of R&D and CMO | F | Common Shares, No Par Value | 2751 | $17.83 | 94,355.0000 | 353,900,000 | 2.83% | 0.00% |
| Dec. 23, 2024 | Bausch & Lomb Corp | $BLCO | Hashad Yehia | EVP of R&D and CMO | F | Common Shares, No Par Value | 2324 | $17.83 | 97,106.0000 | 353,900,000 | 2.34% | 0.00% |
| July 25, 2024 | Bausch & Lomb Corp | $BLCO | Hashad Yehia | EVP of R&D and CMO | F | Common Shares, No Par Value | 2841 | $15.53 | 99,430.0000 | 350,500,000 | 2.78% | 0.00% |
| March 1, 2024 | Bausch & Lomb Corp | $BLCO | Hashad Yehia | EVP of R&D and CMO | F | Common Shares, No Par Value | 2143 | $16.47 | 102,271.0000 | 350,500,000 | 2.05% | 0.00% |
| Feb. 28, 2024 | Bausch & Lomb Corp | $BLCO | Hashad Yehia | EVP of R&D and CMO | A | Common Shares, No Par Value | 20973 | $0.00 | 104,414.0000 | 350,500,000 | 25.14% | 0.01% |
| Feb. 28, 2024 | Bausch & Lomb Corp | $BLCO | Hashad Yehia | EVP of R&D and CMO | A | Non-Qualified Stock Options (right to purchase) | 63516 | $0.00 | 63,516.0000 | 350,500,000 | 9999.99% | 0.02% |